
Pharmacists can help identify uncontrolled risk factors, review medications, and reinforce when patients should seek emergency care.
Panzyga is indicated for the treatment of primary humoral immunodeficiency, chronic inflammatory demyelinating polyneuropathy, and chronic immune thrombocytopenia.
Panzyga (immune globulin intravenous [Human]-ifas) is indicated for the following:





